Harpoon Therapeutics Inc (HARP) Return on Equity ROE from the third quarter 2023 to third quarter 2022 and annually, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Harpoon Therapeutics Inc   (NASDAQ: HARP)

Harpoon Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Harpoon Therapeutics Inc in the third quarter 2023?
Harpoon Therapeutics Inc recorded a cumulative net loss of $-30 million during 12 months ending in the third quarter 2023, resulting in a negative return on equity (ROE) of -893.52%.

Within the Medical Equipment & Supplies industry 188 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2023 from 45 to 4281.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Equity Change -73.15 % -88.75 % -98.27 % -90.7 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -30 -40 -59 -68 -71
Return On Equity (TTM) -893.52 % -619.98 % -473.13 % -299.9 % -198.21 %
HARP's Total Ranking # 4281 # 45 # 1295 # 59 # 59
Equity (TTM) in Millions 5 3 1 5 17
Seq. Equity Change 51.47 % 319.3 % -86.76 % -68.08 % -36.52 %
Seq. Net Income Change - - - - -

Back to HARP Management Effectiveness >> HARP's 5 Years Annual ROE >> Compare HARP ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 189
Sector # 862
Overall # 4281

Return On Equity Statistics
High Average Low
-48.59 %
-224.89 %
-893.52 %
(Dec 31 2019)   (Sep 30 2023)





HARP Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2016)
2018
Total Equity in Millions 5 54 94 -27 0
Y / Y Equity Change -89.97 % -42.86 % - - -
Net Income in Millions -68 -117 -50 -56 -11
Y / Y Net Income Change - - - - -
Return On Equity -1254.51 % -216.8 % -52.97 % - -

Back to HARP Management Effectiveness >> HARP's 5 Years Annual ROE >> Compare HARP ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HARP's' Return on Equity at Yahoo Finance
HARP's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HARP's Competitors
Subscribers only: Roe for Harpoon Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for HARP's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE

Date modified: 2026-09-26T07:35:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.